Your search for ‘Smart & Biggar’ returned 2,497 results

As we approach the one-year anniversary of the coming into force of the Canada-United States-Mexico Agreement (CUSMA) on July 1, 2021, we reflect on the changes that the CUSMA brought about for brand owners, ..

Technology evolves at an ever faster pace. As it evolves, the underlying engineering approaches to technology development and innovation also change.

Regular prices, sale prices, clearance sales – these terms are ubiquitous in the retail world and are a familiar component of marketing strategies intended to convince consumers that now is the best...

Spearheading a start-up is a challenging endeavor at the best of times, let alone in a pandemic. When COVID-19 hit this spring, ...

In September 2023, Health Canada published the Medical Devices Directorate Performance Annual Report for April 1, 2022, through March 31, 2023. The report provides detailed metrics...

We previously reported on Canada's first-ever National Strategy for Drugs for Rare Diseases, which included up to $1.4 billion in funding for provinces and territories...

On December 20, 2025, Health Canada launched a consultation on modernizing the framework for clinical trials involving drugs for human use, including pharmaceuticals, biologics, radiopharmaceuticals, and cannabis.

On January 16, 2017, the Canadian Intellectual Property Office (CIPO) announced a change to its examination practice for computer-generated animated designs.

Canada's Federal Court of Appeal has confirmed that the Court has jurisdiction to order transfer (or delivery up) of a domain name involved in trademark infringement.

On November 5, 2018, Canada's amended legislation governing the protection of industrial designs came into force.

In view of COVID-19, we have compiled a list of important updates as it relates to the pandemic and its impact on Life Sciences. We will continue to update this page as new updates come in.

The Canadian Intellectual Property Office (CIPO) has just announced that applicants can voluntarily include Nice Classification of goods and services in new applications.

On April 8, 2020, the Federal Court of Appeal (FCA) released a decision finding that the Federal Court Notice to the Profession re: Experimental Testing (Notice) does not apply to pre-litigation...

On January 12, 2021, the Federal Court issued its public decision in four patent infringement actions pursuant to subsection 6(1) of the Patented Medicines

Canada has a handy procedure for cancellation of registered marks that are more than 3 years old, and have not been used for 3 years.

La modification règlementaire devrait être déposée cet automne, suivi d'une période de consultation de 45 jours.

The last year has seen numerous contempt proceedings against defendants in copyright litigations. The Ontario Court's decision in Dish Network L.L.C. et al v. Butt et al., 2022 ONSC 1710, ...

In the Final Action, the Examiner rejected all claims in the application as being directed to unpatentable subject matter and lacking utility.